Loading stock data…
$3.44-0.01 (-0.29%)
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
GoodRx Holdings, Inc. in the Healthcare sector is trading at $3.44 with a market capitalization of $1.1B. Wall Street consensus targets $3.95 (12 analysts), implying a +14.8% move over the next 12 months. The stock is currently 20% below its 52-week high of $4.30, remaining 23.7% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $200.41M↑ | $194.01M↓ | $194.78M↓ | $196.03M↓ | $203.07M |
| Gross Profit | $179.41M↑ | $173.85M↓ | $177.32M↓ | $182.61M↓ | $189.72M |
| Operating Income | $23.63M↑ | $14.01M↓ | $22.68M↑ | $14.62M↓ | $26.81M |
| Net Income | $8.54M↑ | $1.17M↓ | $5.42M↑ | $1.12M↓ | $12.84M |
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that prov...